# Effects of Human Leptin Replacement

> **NCT00657605** · PHASE2 · COMPLETED · sponsor: **University of Miami** · enrollment: 3 (actual)

## Conditions studied

- Obesity
- Metabolic Syndrome
- Diabetes

## Interventions

- **DRUG:** Recombinant methionyl human leptin

## Key facts

- **NCT ID:** NCT00657605
- **Lead sponsor:** University of Miami
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-06
- **Primary completion:** 2010-05-04
- **Final completion:** 2010-05-04
- **Target enrollment:** 3 (ACTUAL)
- **Last updated:** 2020-02-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00657605

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00657605, "Effects of Human Leptin Replacement". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00657605. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*